Stay updated on Upadacitinib Combo with Topical Steroids in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib Combo with Topical Steroids in Atopic Dermatitis Clinical Trial page.

Latest updates to the Upadacitinib Combo with Topical Steroids in Atopic Dermatitis Clinical Trial page
- Check4 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; the old revision tag was removed and a new one added. The 'Back to Top' element was removed as a minor UI change.SummaryDifference0.2%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check19 days agoChange DetectedThe webpage has undergone significant updates, including the addition of multiple facility names and locations across Japan, as well as new drug safety information and research references related to upadacitinib. Notably, several previous locations and terms have been removed.SummaryDifference10%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to Upadacitinib Combo with Topical Steroids in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib Combo with Topical Steroids in Atopic Dermatitis Clinical Trial page.